ACC SUP FIXATION TOOL
Boston Scientific · Decision date Sep 16, 2025
What did the FDA decide?
FDA records P960006/S057 as a supplement to PMA P960006, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 16, 2025.
FDA approval order statement
for removing an Ethelyne Oxide (EO) chemical indicator dot applied to the outside of sterile packaging pre-sterilization and evaluated visually post-sterilization
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 16, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P960006/S057
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific
- Product code
- NVN
- Decision code
- OK30
- Decision date
- Sep 16, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Applicant
- Boston Scientific
- Product code
- NVN
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P960006/S057 received
Application receipt date recorded by FDA.
P960006/S057 · FDA decision
30-Day Notice
P960006/S058 · Related supplement
Fixation Tool Model 6616
P960006/S059 · Related supplement
Fixation Tool (Model 6616)
Timeline entries are records held by MedtechLedger for P960006. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960006
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Fixation Tool Model 6616P960006/S058 | Boston Scientific | PMA supplement | Apr 10, 2026 | FDA |
Fixation Tool (Model 6616)P960006/S059 | Boston Scientific | PMA supplement | May 15, 2026 | FDA |
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC SELECTSECURE LEAD MODEL 3830P030036/S162 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 16, 2026 | FDA |
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
SelectSecure Lead 3830P030036/S161 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Aug 5, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA | |
IsoFlex LeadsP960030/S085 | ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P960006/S057
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




